Skip to main content
. 2018 Dec 11;174(2):479–488. doi: 10.1007/s10549-018-05082-y

Table 2.

Results of 79 pathologists responding to our questionnaire on histologic grading of ductal carcinoma in situ (DCIS) of the breast

n (%)
Total (n = 79) Breast pathologist (n = 37) General pathologist (n = 42)
Laboratory
 Academic 15 (19.0%) 11 (29.7%) 4 (9.5%)
 Peripheral 64 (81.0%) 26 (70.3%) 38 (90.5%)
Years of experience
 0–5 28 (35.4%) 11 (29.7%) 17 (40.5%)
 6–10 15 (19.0%) 6 (16.2%) 9 (21.4%)
 11–20 17 (21.5%) 9 (24.3%) 8 (19.0%)
 >20 19 (24.1%) 11 (29.7%) 8 (19.0%)
Based on which guideline or reference do you grade DCIS?a
 Holland et al. [21] 28 (35.4%) 14 (37.8%) 14 (33.3%)
 Pinder et al. [22] 16 (20.3%) 9 (24.3%) 7 (16.7%)
 Intuition 16 (20.3%) 8 (21.6%) 8 (19.0%)
 WHO [23] 11 (13.9%) 5 (13.5%) 6 (14.3%)
 I do not know 4 (5.1%) 0 (0.0%) 4 (9.5%)
 Tavassoli et al. [24] 3 (3.8%) 1 (2.7%) 2 (4.8%)
 Van Nuys (Silverstein et al. [25]) 2 (2.5%) 1 (2.7%) 1 (2.4%)
 College of American Pathologists Guidelines [26] 1 (1.3%) 0 (0.0%) 1 (2.4%)
 Combination (n.o.s.) 1 (1.3%) 1 (2.7%) 0 (0.0%)
How do you grade a DCIS of heterogeneous differentiation?
 Based on the highest grade 60 (76.0%) 28 (75.7%) 32 (76.2%)
 I report the percentages of each grade 9 (11.4%) 4 (10.8%) 5 (11.9%)
 Based on the predominant grade 7 (8.9%) 4 (10.8%) 3 (7.1%)
 Not within the protocol 3 (3.8%) 1 (2.7%) 2 (4.8%)

n.o.s. not otherwise specified

aMultiple answers possible (n = 82)